Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Vanda Pharmaceuticals Inc (NASDAQ:VNDA)

10.61
Delayed Data
As of May 27
 +1.12 / +11.80%
Today’s Change
6.91
Today|||52-Week Range
14.50
+13.96%
Year-to-Date
Bret's Midafternoon Musings
May 27 / TheStreet.com - Paid Partner Content
3 Biotech Stocks to Buy in May
May 16 / MotleyFool.com - Paid Partner Content

Today’s Trading

Previous close9.49
Today’s open9.87
Day’s range9.85 - 10.65
Volume1,994,712
Average volume (3 months)566,234
Market cap$457.9M
Dividend yield--
Data as of 3:59pm ET, 05/27/2016

Growth & Valuation

Earnings growth (last year)-270.91%
Earnings growth (this year)-20.00%
Earnings growth (next 5 years)+19.10%
Revenue growth (last year)+119.16%
P/E ratioNM
Price/Sales3.58
Price/Book3.41

Competitors

 Today’s
change
Today’s
% change
RPTPRaptor Pharmaceutica...+0.33+6.53%
ENTAEnanta Pharmaceutica...+1.20+5.17%
MNKDMannKind Corp-0.02-1.92%
XNPTXenoport Inc+0.02+0.28%
Data as of 3:59pm ET, 05/27/2016

Financials

Next reporting dateJuly 27, 2016
EPS forecast (this quarter)-$0.13
Annual revenue (last year)$109.9M
Annual profit (last year)-$39.9M
Net profit margin-36.27%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Mihael Hristos Polymeropoulos
Chief Financial Officer, Treasurer &
Senior VP
James Patrick Kelly
Corporate headquarters
Washington, District Of Columbia

Forecasts

Partner Offers

Search for Jobs